Spots Global Cancer Trial Database for cholangiocarcinoma of the extrahepatic bile duct

Every month we try and update this database with for cholangiocarcinoma of the extrahepatic bile duct cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder	NCT00084942	Extrahepatic Bi... Gallbladder Can...	capecitabine gemcitabine hyd...	18 Years -	Roswell Park Cancer Institute
BMS-247550 in Treating Patients With Liver or Gallbladder Cancer	NCT00023946	Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Extra... Localized Gallb... Localized Resec... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	ixabepilone laboratory biom...	18 Years -	National Cancer Institute (NCI)
DX-8951f in Treating Patients With Biliary Cancer	NCT00005938	Extrahepatic Bi... Gallbladder Can... Liver Cancer	exatecan mesyla...	16 Years -	Daiichi Sankyo
Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma	NCT03772132	Cholangiocarcin... Gallbladder Can...	mutation and si...	18 Years - 80 Years	Shanghai Jiao Tong University School of Medicine
Radioactive Stents for Treatment of Unresectable Biliary Tract Cancer	NCT02238613	Intrahepatic Ch... Cholangiocarcin... Ampullary Carci... Biliary Obstruc...	radioactive ste... plastic stent	18 Years - 80 Years	307 Hospital of PLA
S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma	NCT00033540	Extrahepatic Bi... Gallbladder Can...	capecitabine gemcitabine hyd...	18 Years -	SWOG Cancer Research Network
S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma	NCT00033540	Extrahepatic Bi... Gallbladder Can...	capecitabine gemcitabine hyd...	18 Years -	SWOG Cancer Research Network
Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers	NCT01229111	Adult Primary C... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Unres... Periampullary A... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	cediranib malea... oxaliplatin leucovorin calc... fluorouracil	18 Years -	National Cancer Institute (NCI)
S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct	NCT00789958	Extrahepatic Bi... Gallbladder Can...	capecitabine gemcitabine hyd... 3-dimensional c... intensity-modul...	18 Years - 120 Years	SWOG Cancer Research Network
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies	NCT01643499	Acinar Cell Ade... Adenocarcinoma ... Adenocarcinoma ... Adult Primary C... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Diffuse Adenoca... Duct Cell Adeno... Intestinal Aden... Localized Unres... Metastatic Carc... Metastatic Extr... Mixed Adenocarc... Mucinous Adenoc... Mucinous Adenoc... Newly Diagnosed... Signet Ring Ade... Signet Ring Ade... Stage III Pancr... Stage IIIA Colo... Stage IIIA Gall... Stage IIIA Gast... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Gall... Stage IIIB Gast... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Rect... Stage IV Gastri... Stage IV Pancre... Stage IVA Colon... Stage IVA Gallb... Stage IVA Recta... Stage IVB Colon... Stage IVB Gallb... Stage IVB Recta... Unresectable Ex...	oxaliplatin irinotecan hydr... leucovorin calc... fluorouracil laboratory biom...	18 Years -	University of Chicago
Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer	NCT00363584	Extrahepatic Bi... Gallbladder Can... Liver Cancer	capecitabine clinical observ... adjuvant therap...	18 Years -	National Cancer Institute (NCI)
Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors	NCT00356889	Cholangiocarcin... Cholangiocarcin... Gastrointestina... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	erlotinib hydro... bevacizumab	18 Years -	National Cancer Institute (NCI)
Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery	NCT00513539	Extrahepatic Bi... Gallbladder Can...	porfimer sodium biliary stentin...	18 Years -	University College, London
Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma	NCT02836847	Cholangiocarcin... Gallbladder Can...	biological test GEMOX Cetuximab Trastuzumab Gefitinib Lapatinib Everolimus Sorafenib Crizotinib	18 Years - 80 Years	Shanghai Jiao Tong University School of Medicine
BMS-247550 in Treating Patients With Liver or Gallbladder Cancer	NCT00023946	Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Extra... Localized Gallb... Localized Resec... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	ixabepilone laboratory biom...	18 Years -	National Cancer Institute (NCI)
Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer	NCT00033462	Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	erlotinib hydro... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer	NCT00363584	Extrahepatic Bi... Gallbladder Can... Liver Cancer	capecitabine clinical observ... adjuvant therap...	18 Years -	National Cancer Institute (NCI)
Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma	NCT03768375	Cholangiocarcin... Gallbladder Can...	conventional ch... conventional ch...	18 Years - 80 Years	Shanghai Jiao Tong University School of Medicine
Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers	NCT00832637	Hepatocellular ... Cholangiocellul... Cholangiocarcin... Bile Duct Cance... Periampullary A... Gallbladder Can... Extrahepatic Bi...	Cisplatin Erlotinib Gemcitabine	18 Years -	New Mexico Cancer Care Alliance
Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer	NCT00003296	Extrahepatic Bi... Gallbladder Can... Liver Cancer	filgrastim pegylated lipos...	18 Years -	National Cancer Institute (NCI)
Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors	NCT00356889	Cholangiocarcin... Cholangiocarcin... Gastrointestina... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	erlotinib hydro... bevacizumab	18 Years -	National Cancer Institute (NCI)
Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery	NCT01859182	Adenocarcinoma ... Adenocarcinoma ... Adult Primary C... Advanced Adult ... Cholangiocarcin... Localized Unres... Metastatic Extr... Recurrent Adult... Recurrent Extra... Stage II Gallbl... Stage IIIA Gall... Stage IIIB Gall... Stage IVA Gallb... Stage IVB Gallb... Unresectable Ex...	selumetinib Akt inhibitor M... laboratory biom... pharmacogenomic... quality-of-life...	18 Years -	National Cancer Institute (NCI)
Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors	NCT00262769	Extrahepatic Bi... Gallbladder Can...	cisplatin gemcitabine hyd...	16 Years -	University College, London
Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery	NCT01313377	Extrahepatic Bi... Gallbladder Can... Liver Cancer	gemcitabine hyd... oxaliplatin clinical observ... adjuvant therap... quality-of-life...	18 Years - 120 Years	UNICANCER
DX-8951f in Treating Patients With Biliary Cancer	NCT00005938	Extrahepatic Bi... Gallbladder Can... Liver Cancer	exatecan mesyla...	16 Years -	Daiichi Sankyo
S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma	NCT00033540	Extrahepatic Bi... Gallbladder Can...	capecitabine gemcitabine hyd...	18 Years -	SWOG Cancer Research Network
Recurrence After Whipple's (RAW) Study	NCT04596865	Pancreatic Canc... Ampullary Cance... Bile Duct Cance... Cholangiocarcin... Cholangiocarcin... Cholangiocarcin... Pancreatic Duct... Pancreatic Duct... Surgery Survivorship Recurrent Cance... Cancer Recurren... Cancer Recurren... Local Recurrenc...	Pancreaticoduod...	-	University Hospital Plymouth NHS Trust
DX-8951f in Treating Patients With Biliary Cancer	NCT00005938	Extrahepatic Bi... Gallbladder Can... Liver Cancer	exatecan mesyla...	16 Years -	Daiichi Sankyo
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies	NCT01643499	Acinar Cell Ade... Adenocarcinoma ... Adenocarcinoma ... Adult Primary C... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Diffuse Adenoca... Duct Cell Adeno... Intestinal Aden... Localized Unres... Metastatic Carc... Metastatic Extr... Mixed Adenocarc... Mucinous Adenoc... Mucinous Adenoc... Newly Diagnosed... Signet Ring Ade... Signet Ring Ade... Stage III Pancr... Stage IIIA Colo... Stage IIIA Gall... Stage IIIA Gast... Stage IIIA Rect... Stage IIIB Colo... Stage IIIB Gall... Stage IIIB Gast... Stage IIIB Rect... Stage IIIC Colo... Stage IIIC Gast... Stage IIIC Rect... Stage IV Gastri... Stage IV Pancre... Stage IVA Colon... Stage IVA Gallb... Stage IVA Recta... Stage IVB Colon... Stage IVB Gallb... Stage IVB Recta... Unresectable Ex...	oxaliplatin irinotecan hydr... leucovorin calc... fluorouracil laboratory biom...	18 Years -	University of Chicago
S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct	NCT00789958	Extrahepatic Bi... Gallbladder Can...	capecitabine gemcitabine hyd... 3-dimensional c... intensity-modul...	18 Years - 120 Years	SWOG Cancer Research Network
Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer	NCT00003296	Extrahepatic Bi... Gallbladder Can... Liver Cancer	filgrastim pegylated lipos...	18 Years -	National Cancer Institute (NCI)
Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas	NCT00003923	Extrahepatic Bi... Gallbladder Can... Liver Cancer Pancreatic Canc...	porfimer sodium	18 Years -	Memorial Sloan Kettering Cancer Center
Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer	NCT00033462	Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	erlotinib hydro... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery	NCT01313377	Extrahepatic Bi... Gallbladder Can... Liver Cancer	gemcitabine hyd... oxaliplatin clinical observ... adjuvant therap... quality-of-life...	18 Years - 120 Years	UNICANCER
Radioactive Stents for Treatment of Unresectable Biliary Tract Cancer	NCT02238613	Intrahepatic Ch... Cholangiocarcin... Ampullary Carci... Biliary Obstruc...	radioactive ste... plastic stent	18 Years - 80 Years	307 Hospital of PLA
Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma	NCT01954745	Bile Duct Cance... Intrahepatic Ch... Cholangiocarcin...	Cabozantinib	18 Years -	Massachusetts General Hospital
Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma	NCT03768375	Cholangiocarcin... Gallbladder Can...	conventional ch... conventional ch...	18 Years - 80 Years	Shanghai Jiao Tong University School of Medicine
BMS-247550 in Treating Patients With Liver or Gallbladder Cancer	NCT00023946	Adult Primary C... Adult Primary H... Advanced Adult ... Cholangiocarcin... Cholangiocarcin... Localized Extra... Localized Gallb... Localized Resec... Localized Unres... Recurrent Adult... Recurrent Extra... Recurrent Gallb... Unresectable Ex... Unresectable Ga...	ixabepilone laboratory biom...	18 Years -	National Cancer Institute (NCI)
B-Receptor Signaling in Cardiomyopathy	NCT01135849	Carcinomas Amyloidosis Anal Cancer Anemia Cholangiocarcin... Transitional Ce... Bone Marrow Tra... Bone Cancer Cancer of Brain... Breast Cancer Carcinoma of th... Endocrine Cance... Esophageal Canc... Eye Cancer Gall Bladder Ca... Gastric (Stomac... Gastrooesophage... Gastrointestina... Gynecologic Can... Head and Neck C... Hepatobiliary N... Kidney (Renal C... Leukemia Lung Cancer Hodgkin Disease Lymphoma, Non-H... Mesothelioma Multiple Myelom... Myelodysplastic... Neuroendocrine ... Myeloproliferat... Pancreatic Canc... Prostate Cancer Skin Cancer Soft Tissue Sar... Testicular Canc... Thymus Cancer Thyroid Cancer		- 40 Years	Stanford University
Biological Therapy in Treating Patients With Metastatic Cancer	NCT00004604	Breast Cancer Colorectal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Head and Neck C... Liver Cancer Lung Cancer Metastatic Canc... Ovarian Cancer Pancreatic Canc... Testicular Germ...	CEA RNA-pulsed ...	18 Years -	Duke University
Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer	NCT00005997	Extrahepatic Bi... Gallbladder Can... Liver Cancer	becatecarin	18 Years -	Case Comprehensive Cancer Center
B-Receptor Signaling in Cardiomyopathy	NCT01135849	Carcinomas Amyloidosis Anal Cancer Anemia Cholangiocarcin... Transitional Ce... Bone Marrow Tra... Bone Cancer Cancer of Brain... Breast Cancer Carcinoma of th... Endocrine Cance... Esophageal Canc... Eye Cancer Gall Bladder Ca... Gastric (Stomac... Gastrooesophage... Gastrointestina... Gynecologic Can... Head and Neck C... Hepatobiliary N... Kidney (Renal C... Leukemia Lung Cancer Hodgkin Disease Lymphoma, Non-H... Mesothelioma Multiple Myelom... Myelodysplastic... Neuroendocrine ... Myeloproliferat... Pancreatic Canc... Prostate Cancer Skin Cancer Soft Tissue Sar... Testicular Canc... Thymus Cancer Thyroid Cancer		- 40 Years	Stanford University
Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma	NCT03768375	Cholangiocarcin... Gallbladder Can...	conventional ch... conventional ch...	18 Years - 80 Years	Shanghai Jiao Tong University School of Medicine

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: